Hydrocortamate
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,
16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 2-(diethylamino)acetate | |
| Clinical data | |
| Routes of administration | Topical |
| Pharmacokinetic data | |
| Excretion | Hepatic |
| Identifiers | |
| CAS Number | 76-47-1 |
| PubChem | CID 408334 |
| DrugBank | DB00769 |
| ChemSpider | 361312 |
| UNII | Y3N00BK5WK |
| ChEBI | CHEBI:50851 |
| ChEMBL | CHEMBL1201263 |
| Synonyms | Hydrocortamate Hydrochloride, Magnacort, Ulcort |
| Chemical data | |
| Formula | C27H41NO6 |
| Molar mass | 475.61754 g/mol |
| |
| |
Hydrocortamate (Magnacort, Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.[1]
References
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, January 30, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
